Literature DB >> 18657935

Prescription Opioid Misuse Index: a brief questionnaire to assess misuse.

Janet S Knisely1, Martha J Wunsch, Karen L Cropsey, Eleanor D Campbell.   

Abstract

The Prescription Opioid Misuse Index (POMI) was developed and used in a larger study designed to assess correlates of OxyContin abuse in pain patients prescribed OxyContin, patients treated for OxyContin addiction, and individuals incarcerated for OxyContin-related charges. The POMI was administered to 40 subjects with addiction problems and 34 pain patients who had received OxyContin for pain. Receiver operating characteristic curve analysis indicated that endorsing two or more of six items reliably classified a person as at risk for misuse of their medication. When comparing drug abuse/dependence in subjects classified as misusers or users, significantly more misusers received a diagnosis for alcohol (p < .01), illicit drugs (p < .05), and other prescription medications (p < .05) and reported greater lifetime use of alcohol (p < .002) and illicit drugs (p < .01). No between-group differences were found regarding psychiatric problems. The POMI appears to be a sensitive and specific instrument for identifying patients who misuse opioid medications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657935     DOI: 10.1016/j.jsat.2008.02.001

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  39 in total

Review 1.  Nonmedical use of prescription medications in young adults.

Authors:  Brian E Tapscott; Ty S Schepis
Journal:  Adolesc Med State Art Rev       Date:  2013-12

2.  Developing a framework of care for opioid medication misuse in community pharmacy.

Authors:  Gerald Cochran; Adam J Gordon; Craig Field; Jennifer Bacci; Ranjita Dhital; Thomas Ylioja; Maxine Stitzer; Thomas Kelly; Ralph Tarter
Journal:  Res Social Adm Pharm       Date:  2015-05-08

3.  Prescription opioid use: Patient characteristics and misuse in community pharmacy.

Authors:  Gerald Cochran; Jennifer L Bacci; Thomas Ylioja; Valerie Hruschak; Sharon Miller; Amy L Seybert; Ralph Tarter
Journal:  J Am Pharm Assoc (2003)       Date:  2016-03-24

4.  Opioid medication misuse among unhealthy drinkers.

Authors:  Gerald Cochran; Rebecca McCarthy; Adam J Gordon; Ralph E Tarter
Journal:  Drug Alcohol Depend       Date:  2017-07-14       Impact factor: 4.492

Review 5.  Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review.

Authors:  Shannon M Smith; Florence Paillard; Andrew McKeown; Laurie B Burke; Robert R Edwards; Nathaniel P Katz; Elektra J Papadopoulos; Bob A Rappaport; Ashley Slagle; Eric C Strain; Ajay D Wasan; Dennis C Turk; Robert H Dworkin
Journal:  J Pain       Date:  2015-02-04       Impact factor: 5.820

6.  Prescription Opioid Misuse Among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research.

Authors:  Gerald T Cochran; Rafael J Engel; Valerie J Hruschak; Ralph E Tarter
Journal:  J Pharm Pract       Date:  2016-07-08

7.  Screening Community Pharmacy Patients for Risk of Prescription Opioid Misuse.

Authors:  Gerald Cochran; Jessica Rubinstein; Jennifer L Bacci; Thomas Ylioja; Ralph Tarter
Journal:  J Addict Med       Date:  2015 Sep-Oct       Impact factor: 3.702

8.  Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis.

Authors:  Gerald Cochran; Valerie Hruschak; Jennifer L Bacci; Kenneth C Hohmeier; Ralph Tarter
Journal:  Res Social Adm Pharm       Date:  2016-11-15

9.  Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments.

Authors:  Sebastian T Tong; Kathryn M Polak; Michael F Weaver; Gabriela C Villalobos; Wally R Smith; Dace S Svikis
Journal:  J Am Board Fam Med       Date:  2019 Mar-Apr       Impact factor: 2.657

10.  Characteristics of methadone maintenance treatment patients prescribed opioid analgesics.

Authors:  Matthew C Glenn; Nancy L Sohler; Joanna L Starrels; Jeronimo Maradiaga; John J Jost; Julia H Arnsten; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2016-01-05       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.